MRI and MRSpredictors of mild cognitive impairment in a population-based sample

Neurology

Volumn 81, Issue 2, 2013, Pages 126-133

  Kantarci, Kejal ^a   Weigand, Stephen D ^a   Przybelski, Scott A ^a   Preboske, Gregory M ^a   Pankratz, V Shane ^a   Vemuri, Prashanthi ^a   Senjem, Matthew L ^a   Murphy, Matthew C ^a   Gunter, Jeffrey L ^a   Machulda, Mary M ^a   Ivnik, Robert J ^a   Roberts, Rosebud O ^a   Boeve, Bradley F ^b   Rocca, Walter A ^a,b   Knopman, David S ^b   Petersen, Ronald C ^b   Jack, Clifford R ^a  

^a Health Sciences Research   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL; N ACETYLASPARTIC ACID;

AGED; ARTICLE; BRAIN INFARCTION; BRAIN SIZE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COGNITION; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION BASED CASE CONTROL STUDY; POSTERIOR CINGULATE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; RISK FACTOR; VOXEL BASED MORPHOMETRY; WECHSLER MEMORY SCALE; WHITE MATTER; AGING; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRODROMAL SYMPTOM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MILD COGNITIVE IMPAIRMENT; PREDICTIVE VALUE OF TESTS; PRODROMAL SYMPTOMS; PROPORTIONAL HAZARDS MODELS;

EID: 84881274344     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31829a3329     Document Type: Article

References (38)

1. Morris JC, Kimberly A, Quaid K, et al. Role of biomarkers in studies of presymptomatic Alzheimer's disease. Alzheimers Dement 2005;1:145-151
2. Knopman DS, Parisi JE, Salviati A, et al. Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 2003;62:1087-1095
3. Sonnen JA, Santa Cruz K, Hemmy LS, et al. Ecology of the aging human brain. Arch Neurol 2011;68:1049-1056
4. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 2009;66:200-208
5. Jack CR Jr, Dickson DW, Parisi JE, et al. AntemortemMRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002;58:750-757
6. Kantarci K, Knopman DS, Dickson DW, et al. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. Radiology 2008;248:210-220
7. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222
8. Smith EE, Egorova S, Blacker D, et al. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol 2008;65:94-100
9. Silbert LC, Nelson C, Howieson DB, Moore MM, Kaye JA. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 2008;71:108-113
10. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001; 58:643-647
11. Debette S, Beiser A, DeCarli C, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010;41:600-606
12. Zimmerman ME, Pan JW, Hetherington HP, et al. Hippocampal neurochemistry, neuromorphometry, and verbal memory in nondemented older adults. Neurology 2008; 70:1594-1600
13. Kantarci K, Petersen RC, Przybelski SA, et al. Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. Arch Neurol 2008;65:1621-1628
14. Chao LL, Schuff N, Kramer JH, et al. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology 2005;64:282-289
15. Kantarci K, Weigand SD, Przybelski SA, et al. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology 2009;72: 1519-1525
16. Roberts RO, Geda YE, Knopman DS, et al. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 2008;30:58-69
17. Petersen RC, Roberts RO, Knopman DS, et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology 2010;75:889-897
18. American Pychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R. Washington, DC: American Pychiatric Association; 1987
19. Jack CR Jr, BernsteinMA, Borowski BJ, et al.Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement 2010;6:212-220
20. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341-355
21. Raz L, Jayachandran M, Tosakulwong N, et al. Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women. Neurology 2013;80:911-918
22. Kantarci K, Jack CR Jr, Xu YC, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology 2000;55:210-217
23. Roberts RO, Geda YE, Knopman DS, et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology 2012;78:342-351
24. Kantarci K. 1H magnetic resonance spectroscopy in dementia. Br J Radiol 2007;80:S146-S152
25. Schott JM, Frost C, MacManus DG, Ibrahim F, Waldman AD, Fox NC. Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study. Brain 2010;133:3315-3322
26. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-292
27. Jack CR Jr, Knopman DS, Weigand SD, et al. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol 2012;71:765-775
28. Knopman DS, Jack CR Jr, Wiste HJ, et al. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology 2012;78:1576-1582
29. Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 2011;10:785-796
30. Whitwell JL, Dickson D, Murray ME, Petersen RC, Jack CR Jr, Josephs KA. MRI in pathologically defined hippocampal sparing and limbic predominant atypical variants of Alzheimer's disease. Alzheimers Dement 2012; 8:P9.
31. Whitwell JL, Jack CR Jr, Kantarci K, et al. Imaging correlates of posterior cortical atrophy. Neurobiol Aging 2007;28:1051-1061
32. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128: 2034-2041
33. De Groot JC, De Leeuw FE, Oudkerk M, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 2002;52:335-341
34. Kantarci K, Petersen RC, Boeve BF, et al. 1H MR spectroscopy in common dementias. Neurology 2004;63: 1393-1398
35. Shiino A, Watanabe T, Shirakashi Y, et al. The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy. J Cereb Blood Flow Metab 2012;32:805-815
36. MacKay S, Meyerhoff DJ, Constans JM, Norman D, Fein G, Weiner MW. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol 1996;53:167-174
37. Knopman DS, Roberts RO, Geda YE, et al. Association of prior stroke with cognitive function and cognitive impairment: a population-based study. Arch Neurol 2009;66: 614-619
38. Rasquin SM, van Oostenbrugge RJ, Verhey FR, Lodder J. Vascular mild cognitive impairment is highly prevalent after lacunar stroke but does not increase over time: a 2-year follow-up study. Dement Geriatr Cogn Disord 2007;24: 396-401